Skip to main content
Erschienen in: World Journal of Surgery 7/2008

01.07.2008

Thyroid Incidentaloma: An Evidence-based Assessment of Management Strategy

verfasst von: Jenny Gough, David Scott-Coombes, F. Fausto Palazzo

Erschienen in: World Journal of Surgery | Ausgabe 7/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Palpable thyroid nodules are present in 4–7% of the population and their prevalence increases with age. Thyroid incidentalomas—impalpable nodules detected fortuitously during a radiological investigation—may be found in up to 50% of patients. Although numerous guidelines exist that indicate the appropriate management of palpable thyroid nodules, there are no accepted guidelines for the increasingly common thyroid incidentaloma. Presently no level I or II evidence exists on this topic.

Methods

Systematic review of the literature using evidence-based criteria was performed.

Results

Thyroid incidentalomas are common and are mostly benign lesions. A small proportion is malignant, mainly papillary thyroid microcarcinomas (PTMC). Lesions <5 mm in diameter, even if PTMC, exceptionally metastasize and can be safely left. Lesions between 5 mm and 9 mm without sinister radiological features need not be investigated. The appropriate follow-up is controversial.

Conclusion

It is unlikely that a trial of sufficient power to demonstrate or refute the beneficial effects of presymptomatic investigation of thyroid nodules will take place. We propose a pragmatic approach based on current evidence that balances the benefit of early diagnosis and treatment with the cost to the patient and the healthcare system associated with unnecessary investigations and surgery.
Literatur
1.
Zurück zum Zitat Hedegus L (2004) Clinical practice: the thyroid nodule. N Engl J Med 351:1764–1771CrossRef Hedegus L (2004) Clinical practice: the thyroid nodule. N Engl J Med 351:1764–1771CrossRef
2.
Zurück zum Zitat Vander JB, Gaston EA, Dawber TR (1968) The significance of non-toxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Internal Med 69:537–540 Vander JB, Gaston EA, Dawber TR (1968) The significance of non-toxic thyroid nodules: final report of a 15-year study of the incidence of thyroid malignancy. Ann Internal Med 69:537–540
3.
Zurück zum Zitat Turnbridge WMG, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol 7:481–493CrossRef Turnbridge WMG, Evered DC, Hall R et al (1977) The spectrum of thyroid disease in a community: the Wickham survey. Clin Endocrinol 7:481–493CrossRef
4.
Zurück zum Zitat Oertel JE, Klinck GH (1965) Structural changes in the thyroid glands of healthy young men. Med Ann 34:75–77 Oertel JE, Klinck GH (1965) Structural changes in the thyroid glands of healthy young men. Med Ann 34:75–77
5.
Zurück zum Zitat Mortensen J, Woolner L, Bennett W (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280PubMedCrossRef Mortensen J, Woolner L, Bennett W (1955) Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 15:1270–1280PubMedCrossRef
6.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1–33CrossRef Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:1–33CrossRef
7.
Zurück zum Zitat Gharib H, Papini E, Valcavi R et al (2006) American association of clinical endocrinologists and Associazone Medici Endocrinologi medical guidelines for the clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–102PubMed Gharib H, Papini E, Valcavi R et al (2006) American association of clinical endocrinologists and Associazone Medici Endocrinologi medical guidelines for the clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63–102PubMed
8.
Zurück zum Zitat Frates MC, Benson CB, Charboneau JW et al (2006) Management of thyroid nodules detected at US, Society of Radiologists in Ultrasound Consensus Conference Statement. Ultrasound Q 22:231–238PubMedCrossRef Frates MC, Benson CB, Charboneau JW et al (2006) Management of thyroid nodules detected at US, Society of Radiologists in Ultrasound Consensus Conference Statement. Ultrasound Q 22:231–238PubMedCrossRef
9.
Zurück zum Zitat British association of endocrine and thyroid surgeons (BAES) guidelines on training and management of endocrine disease. 1999. Available at: www.baes.info/pages/guidelines.php British association of endocrine and thyroid surgeons (BAES) guidelines on training and management of endocrine disease. 1999. Available at: www.baes.info/pages/guidelines.php
10.
Zurück zum Zitat Tan GH, Gharib H, Reading CC (1995) Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Int Med 155:2418–2423CrossRef Tan GH, Gharib H, Reading CC (1995) Solitary thyroid nodule. Comparison between palpation and ultrasonography. Arch Int Med 155:2418–2423CrossRef
11.
Zurück zum Zitat Rozycki GS (1998) Surgeon-performed ultrasound: its use in clinical practice. Ann Surg 228:16–28PubMedCrossRef Rozycki GS (1998) Surgeon-performed ultrasound: its use in clinical practice. Ann Surg 228:16–28PubMedCrossRef
12.
Zurück zum Zitat Reiners C, Wegscheider K, Schicha H et al (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 926–932 Reiners C, Wegscheider K, Schicha H et al (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 926–932
13.
Zurück zum Zitat Steele SR, Martin MJ, Mullenix PS et al (2005) The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Arch Surg 140:981–985PubMedCrossRef Steele SR, Martin MJ, Mullenix PS et al (2005) The significance of incidental thyroid abnormalities identified during carotid duplex ultrasonography. Arch Surg 140:981–985PubMedCrossRef
14.
Zurück zum Zitat Shetty SK, Maher MM, Hahn PF et al (2006) Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol 187:1349–1356PubMedCrossRef Shetty SK, Maher MM, Hahn PF et al (2006) Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR Am J Roentgenol 187:1349–1356PubMedCrossRef
15.
Zurück zum Zitat Youserm DM, Huang T, Loevner LA et al (1997) Clinical and economic impact of incidental thyroid lesions found with CT and MR. Am J Neuroradiol 18:1423–1428PubMed Youserm DM, Huang T, Loevner LA et al (1997) Clinical and economic impact of incidental thyroid lesions found with CT and MR. Am J Neuroradiol 18:1423–1428PubMed
16.
Zurück zum Zitat Chu QD, Connor MS, Lilien DL et al (2006) Positron emission tomography (PET) positive thyroid incidentalomas: the risk of malignancy observed in a tertiary referral centre. Am Surg 72:272–275PubMed Chu QD, Connor MS, Lilien DL et al (2006) Positron emission tomography (PET) positive thyroid incidentalomas: the risk of malignancy observed in a tertiary referral centre. Am Surg 72:272–275PubMed
17.
Zurück zum Zitat Cohen MS, Arslan N, Dehdshti F et al (2001) Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 941–946 Cohen MS, Arslan N, Dehdshti F et al (2001) Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 941–946
18.
Zurück zum Zitat Kang KW, Kim S, Kang H et al (2003) Prevalence and risk of cancer of focal incidentaloma identified by 18F-Fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88:4100–4104PubMedCrossRef Kang KW, Kim S, Kang H et al (2003) Prevalence and risk of cancer of focal incidentaloma identified by 18F-Fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrinol Metab 88:4100–4104PubMedCrossRef
19.
Zurück zum Zitat Sackett D (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95:2S–4SPubMedCrossRef Sackett D (1989) Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 95:2S–4SPubMedCrossRef
20.
Zurück zum Zitat Heinrich S, Schafer M, Rousson V, Clavien PA (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243:154–168PubMedCrossRef Heinrich S, Schafer M, Rousson V, Clavien PA (2006) Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 243:154–168PubMedCrossRef
21.
Zurück zum Zitat Kim EK, Park CS, Chung WY et al (2002) New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 178:687–691PubMed Kim EK, Park CS, Chung WY et al (2002) New sonographic criteria for recommending fine-needle aspiration biopsy of nonpalpable solid nodules of the thyroid. AJR Am J Roentgenol 178:687–691PubMed
22.
Zurück zum Zitat Papini E, Guglielmi R, Bianchini A et al (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and colour Doppler features. J Clin Endocrinol Metab 87:1941–1946PubMedCrossRef Papini E, Guglielmi R, Bianchini A et al (2002) Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and colour Doppler features. J Clin Endocrinol Metab 87:1941–1946PubMedCrossRef
23.
Zurück zum Zitat Nam-Goong IS, Kim HY, Gong G et al (2004) Ultrasonographically-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol 60:21–28CrossRef Nam-Goong IS, Kim HY, Gong G et al (2004) Ultrasonographically-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol 60:21–28CrossRef
24.
Zurück zum Zitat Chen YK, Ding HJ, Chen KT et al (2005) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25(2B):1421–1426PubMed Chen YK, Ding HJ, Chen KT et al (2005) Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for cancer screening in healthy subjects. Anticancer Res 25(2B):1421–1426PubMed
25.
Zurück zum Zitat Hundahl SA, Fleming ID, Fremgen AM et al (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648PubMedCrossRef Hundahl SA, Fleming ID, Fremgen AM et al (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648PubMedCrossRef
26.
Zurück zum Zitat Ross D (2002) Editorial: nonpalpable thyroid nodules – managing an epidemic. J Clin Endocrinol Metab 87:1938–1940PubMedCrossRef Ross D (2002) Editorial: nonpalpable thyroid nodules – managing an epidemic. J Clin Endocrinol Metab 87:1938–1940PubMedCrossRef
27.
Zurück zum Zitat Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French thyroid cancer committee. Thyroid 14:1056–1060PubMedCrossRef Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French thyroid cancer committee. Thyroid 14:1056–1060PubMedCrossRef
28.
Zurück zum Zitat Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167PubMedCrossRef Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 295:2164–2167PubMedCrossRef
29.
Zurück zum Zitat Leenhardt L, Hejblum G, Franc B et al (1999) Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 84:24–28PubMedCrossRef Leenhardt L, Hejblum G, Franc B et al (1999) Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. J Clin Endocrinol Metab 84:24–28PubMedCrossRef
30.
Zurück zum Zitat Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid: a “normal” finding in Finland. Cancer 56:531–538PubMedCrossRef Harach HR, Franssila KO, Wasenius VM (1985) Occult papillary carcinoma of the thyroid: a “normal” finding in Finland. Cancer 56:531–538PubMedCrossRef
31.
Zurück zum Zitat Wang C, Crapo L (1997) The epidemiology of thyroid disease and the implications for screening. Endocrinol Metab Clin North Am 26:189–218PubMedCrossRef Wang C, Crapo L (1997) The epidemiology of thyroid disease and the implications for screening. Endocrinol Metab Clin North Am 26:189–218PubMedCrossRef
32.
Zurück zum Zitat Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J et al (1993) Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 71:4022–4029PubMedCrossRef Martinez-Tello FJ, Martinez-Cabruja R, Fernandez-Martin J et al (1993) Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods. Cancer 71:4022–4029PubMedCrossRef
33.
Zurück zum Zitat Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463PubMedCrossRef Mazzaferri EL, Kloos RT (2001) Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 86:1447–1463PubMedCrossRef
34.
Zurück zum Zitat Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumour size in papillary and follicular thyroid carcinoma. Cancer 103:2269–2273PubMedCrossRef Machens A, Holzhausen HJ, Dralle H (2005) The prognostic value of primary tumour size in papillary and follicular thyroid carcinoma. Cancer 103:2269–2273PubMedCrossRef
35.
Zurück zum Zitat Chow SM, Law SC, Chan JK et al (2003) Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40PubMedCrossRef Chow SM, Law SC, Chan JK et al (2003) Papillary microcarcinoma of the thyroid: prognostic significance of lymph node metastasis and multifocality. Cancer 98:31–40PubMedCrossRef
36.
Zurück zum Zitat Ito Y, Uruno T, Nakano K et al (2003) An observational trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 381–387 Ito Y, Uruno T, Nakano K et al (2003) An observational trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 381–387
37.
Zurück zum Zitat Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Int Med 126:226–231PubMed Tan GH, Gharib H (1997) Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging. Ann Int Med 126:226–231PubMed
38.
Zurück zum Zitat Haugen BR, Woodmansee WW, McDermott MT (2002) Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol 56:281–290CrossRef Haugen BR, Woodmansee WW, McDermott MT (2002) Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clin Endocrinol 56:281–290CrossRef
Metadaten
Titel
Thyroid Incidentaloma: An Evidence-based Assessment of Management Strategy
verfasst von
Jenny Gough
David Scott-Coombes
F. Fausto Palazzo
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 7/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9503-2

Weitere Artikel der Ausgabe 7/2008

World Journal of Surgery 7/2008 Zur Ausgabe

Letter

Reply

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.